ArticleOncology letters2025

Efficacy and safety of antibody drug conjugate therapy in patients with human epidermal growth factor receptor 2-positive non-small cell lung cancer: A single-arm systematic review and meta-analysis.

Fanfei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.